{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T11:43:24Z","timestamp":1794051804698,"version":"4.8.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016036","name":"Health~Holland","doi-asserted-by":"publisher","award":["EMCLSH20022"],"award-info":[{"award-number":["EMCLSH20022"]}],"id":[{"id":"10.13039\/100016036","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.biopha.2025.118773","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T16:18:08Z","timestamp":1763050688000},"page":"118773","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["A phenotype-driven data and drug repurposing strategy used to identify potential treatments targeting chondrocyte hypertrophy in osteoarthritis"],"prefix":"10.1016","volume":"193","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-9158-6188","authenticated-orcid":false,"given":"Judith","family":"Veldman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2639-0724","authenticated-orcid":false,"given":"Mauricio N.","family":"Ferrao Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Kops","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy J.L.M.","family":"Koevoet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric M.J.","family":"Bindels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0283-7069","authenticated-orcid":false,"given":"Gregory","family":"van Beek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remco M.","family":"Hoogenboezem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavitha","family":"Sivasubramaniyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"van Rooij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Lolli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Farrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1852-6409","authenticated-orcid":false,"given":"Gerjo J.V.M.","family":"van Osch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.biopha.2025.118773_bib1","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.mcna.2019.10.007","article-title":"Osteoarthritis: pathology, diagnosis, and treatment options","volume":"104","author":"Abramoff","year":"2020","journal-title":"Med. Clin. North Am."},{"issue":"9","key":"10.1016\/j.biopha.2025.118773_bib2","doi-asserted-by":"crossref","first-page":"e508","DOI":"10.1016\/S2665-9913(23)00163-7","article-title":"Global, regional, and national burden of osteoarthritis, 1990-2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021","volume":"5","author":"Collaborators","year":"2023","journal-title":"Lancet Rheuma"},{"key":"10.1016\/j.biopha.2025.118773_bib3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0074-7696(08)62109-9","article-title":"Chondrocyte differentiation","volume":"159","author":"Cancedda","year":"1995","journal-title":"Int Rev. Cytol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118773_bib4","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.joca.2011.12.003","article-title":"Chondrocyte hypertrophy and osteoarthritis: role in initiation and progression of cartilage degeneration?","volume":"20","author":"van der Kraan","year":"2012","journal-title":"Osteoarthr. Cartil."},{"issue":"6","key":"10.1016\/j.biopha.2025.118773_bib5","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nm.2146","article-title":"Transcriptional regulation of endochondral ossification by HIF-2alpha during skeletal growth and osteoarthritis development","volume":"16","author":"Saito","year":"2010","journal-title":"Nat. Med"},{"issue":"3","key":"10.1016\/j.biopha.2025.118773_bib6","first-page":"527","article-title":"Identifying new antiepileptic drugs through genomics-based drug repurposing","volume":"26","author":"Mirza","year":"2017","journal-title":"Hum. Mol. Genet"},{"issue":"6","key":"10.1016\/j.biopha.2025.118773_bib7","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.cmet.2011.03.020","article-title":"mRNA expression signatures of human skeletal muscle atrophy identify a natural compound that increases muscle mass","volume":"13","author":"Kunkel","year":"2011","journal-title":"Cell Metab."},{"issue":"3","key":"10.1016\/j.biopha.2025.118773_bib8","doi-asserted-by":"crossref","first-page":"791","DOI":"10.15252\/msb.20145486","article-title":"Drugs that reverse disease transcriptomic signatures are more effective in a mouse model of dyslipidemia","volume":"11","author":"Wagner","year":"2015","journal-title":"Mol. Syst. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118773_bib9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"10081","key":"10.1016\/j.biopha.2025.118773_bib10","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/S0140-6736(17)30823-1","article-title":"Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: a phase 2, randomised, double-blind, placebo-controlled trial,\"","volume":"389","author":"Prague","year":"2017","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.biopha.2025.118773_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.841","article-title":"Drug repurposing strategies of relevance for Parkinson's disease","volume":"9","author":"Fletcher","year":"2021","journal-title":"Pharm. Res Perspect."},{"issue":"41","key":"10.1016\/j.biopha.2025.118773_bib12","doi-asserted-by":"crossref","first-page":"16666","DOI":"10.1073\/pnas.1202529109","article-title":"Clinical trial of a farnesyltransferase inhibitor in children with Hutchinson-Gilford progeria syndrome","volume":"109","author":"Gordon","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8","key":"10.1016\/j.biopha.2025.118773_bib13","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1182\/blood-2005-02-0488","article-title":"Gefitinib induces myeloid differentiation of acute myeloid leukemia","volume":"106","author":"Stegmaier","year":"2005","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.biopha.2025.118773_bib14","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: identifying and developing new uses for existing drugs,\"","volume":"3","author":"Ashburn","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.biopha.2025.118773_bib15","doi-asserted-by":"crossref","first-page":"10868","DOI":"10.1038\/s41598-020-67730-y","article-title":"Synovial cell cross-talk with cartilage plays a major role in the pathogenesis of osteoarthritis","volume":"10","author":"Chou","year":"2020","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.biopha.2025.118773_bib16","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s10565-020-09532-6","article-title":"\"MSC encapsulation in alginate microcapsules prolongs survival after intra-articular injection, a longitudinal in vivo cell and bead integrity tracking study,\"","volume":"36","author":"Khatab","year":"2020","journal-title":"Cell Biol. Toxicol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118773_bib17","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0945-053X(00)00068-8","article-title":"Osteopontin is expressed by adult human osteoarthritic chondrocytes: protein and mRNA analysis of normal and osteoarthritic cartilage","volume":"19","author":"Pullig","year":"2000","journal-title":"Matrix Biol."},{"issue":"12","key":"10.1016\/j.biopha.2025.118773_bib18","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.joca.2013.08.018","article-title":"Consequences of chondrocyte hypertrophy on osteoarthritic cartilage: potential effect on angiogenesis","volume":"21","author":"Pesesse","year":"2013","journal-title":"Osteoarthr. Cartil."},{"issue":"3","key":"10.1016\/j.biopha.2025.118773_bib19","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00418-005-0773-6","article-title":"Vascular endothelial growth factor plays an important autocrine\/paracrine role in the progression of osteoarthritis","volume":"123","author":"Tanaka","year":"2005","journal-title":"Histochem Cell Biol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118773_bib20","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1136\/annrheumdis-2020-218089","article-title":"Microenvironment in subchondral bone: predominant regulator for the treatment of osteoarthritis","volume":"80","author":"Hu","year":"2021","journal-title":"Ann. Rheum. Dis."},{"issue":"7","key":"10.1016\/j.biopha.2025.118773_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/cells11071232","article-title":"Identification of transcription factors responsible for a transforming growth factor-\u03b2-driven hypertrophy-like phenotype in human osteoarthritic chondrocytes","volume":"11","author":"Thielen","year":"2022","journal-title":"Cells"},{"issue":"7838","key":"10.1016\/j.biopha.2025.118773_bib22","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41586-020-2760-4","article-title":"Structural basis for the action of the drug trametinib at KSR-bound MEK","volume":"588","author":"Khan","year":"2020","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.biopha.2025.118773_bib23","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.3390\/molecules28041683","article-title":"Connection between osteoarthritis and nitric oxide: from pathophysiology to therapeutic target","volume":"28","author":"Jiang","year":"2023","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.biopha.2025.118773_bib24","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1136\/annrheumdis-2017-212863","article-title":"Single-cell RNA-seq analysis reveals the progression of human osteoarthritis","volume":"78","author":"Ji","year":"2019","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.biopha.2025.118773_bib25","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.1038\/s41598-020-62463-4","article-title":"Hypoxia-inducible factor-1 alpha maintains mouse articular cartilage through suppression of NF-\u03baB signaling,\"","volume":"10","author":"Okada","year":"2020","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.biopha.2025.118773_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2019.06.004","article-title":"\u03b1B-crystallin (CRYAB) regulates the proliferation, apoptosis, synthesis and degradation of extracellular matrix of chondrocytes in osteoarthritis","volume":"382","author":"Bao","year":"2019","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.biopha.2025.118773_bib27","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.freeradbiomed.2021.12.257","article-title":"Systemic administration of a pharmacologic iron chelator reduces cartilage lesion development in the Dunkin-Hartley model of primary osteoarthritis","volume":"179","author":"Burton","year":"2022","journal-title":"Free Radic. Biol. Med"},{"issue":"3","key":"10.1016\/j.biopha.2025.118773_bib28","doi-asserted-by":"crossref","DOI":"10.1111\/jfbc.12755","article-title":"Epicatechin and scopoletin rich Morinda citrifolia (Noni) leaf extract supplementation, mitigated Osteoarthritis via anti-inflammatory, anti-oxidative, and anti-protease pathways","volume":"43","author":"Wan Osman","year":"2019","journal-title":"J. Food Biochem"},{"issue":"4","key":"10.1016\/j.biopha.2025.118773_bib29","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.semarthrit.2015.11.011","article-title":"Efficacy and safety of glucosamine sulfate in the management of osteoarthritis: evidence from real-life setting trials and surveys","volume":"45","author":"Bruy\u00e8re","year":"2016","journal-title":"Semin Arthritis Rheum."},{"issue":"11","key":"10.1016\/j.biopha.2025.118773_bib30","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1002\/jbm.a.35495","article-title":"Chondroprotective effect of zinc oxide nanoparticles in conjunction with hypoxia on bovine cartilage-matrix synthesis","volume":"103","author":"Mirza","year":"2015","journal-title":"J. Biomed. Mater. Res A"},{"issue":"1","key":"10.1016\/j.biopha.2025.118773_bib31","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41413-020-00109-x","article-title":"Classification of four distinct osteoarthritis subtypes with a knee joint tissue transcriptome atlas","volume":"8","author":"Yuan","year":"2020","journal-title":"Bone Res."},{"issue":"9","key":"10.1016\/j.biopha.2025.118773_bib32","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1093\/rheumatology\/kev100","article-title":"Distinct subtypes of knee osteoarthritis: data from the osteoarthritis Initiative","volume":"54","author":"Waarsing","year":"2015","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/j.biopha.2025.118773_bib33","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1093\/rheumatology\/keaa391","article-title":"Identification and characterization of two consistent osteoarthritis subtypes by transcriptome and clinical data integration","volume":"60","author":"Coutinho de Almeida","year":"2021","journal-title":"Rheumatol. (Oxf. )"},{"issue":"11","key":"10.1016\/j.biopha.2025.118773_bib34","doi-asserted-by":"crossref","first-page":"7303","DOI":"10.1007\/s11033-021-06731-0","article-title":"Increase in NO causes osteoarthritis and chondrocyte apoptosis and chondrocyte ERK plays a protective role in the process","volume":"48","author":"Chen","year":"2021","journal-title":"Mol. Biol. Rep."},{"issue":"4","key":"10.1016\/j.biopha.2025.118773_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/cells9040927","article-title":"Noggin Inhibits IL-1beta and BMP-2 expression, and attenuates cartilage degeneration and subchondral bone destruction in experimental osteoarthritis","volume":"9","author":"Chien","year":"2020","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.biopha.2025.118773_bib36","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1002\/cbin.11293","article-title":"Protective effects of cilengitide on inflammation in chondrocytes under excessive mechanical stress","volume":"44","author":"Hirose","year":"2020","journal-title":"Cell Biol. Int"},{"issue":"46","key":"10.1016\/j.biopha.2025.118773_bib37","doi-asserted-by":"crossref","first-page":"31972","DOI":"10.1074\/jbc.M109.056838","article-title":"Oxidative stress inhibits insulin-like growth factor-I induction of chondrocyte proteoglycan synthesis through differential regulation of phosphatidylinositol 3-Kinase-Akt and MEK-ERK MAPK signaling pathways","volume":"284","author":"Yin","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.biopha.2025.118773_bib38","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ccr.2014.03.011","article-title":"Disruption of CRAF-mediated MEK activation is required for effective MEK inhibition in KRAS mutant Tumors","volume":"25","author":"Lito","year":"2014","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.biopha.2025.118773_bib39","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13046-015-0222-x","article-title":"Targeted inhibition of MEK1 by cobimetinib leads to differentiation and apoptosis in neuroblastoma cells","volume":"34","author":"Singh","year":"2015","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"7466","key":"10.1016\/j.biopha.2025.118773_bib40","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nature12441","article-title":"Mechanism of MEK inhibition determines efficacy in mutant KRAS- versus BRAF-driven cancers","volume":"501","author":"Hatzivassiliou","year":"2013","journal-title":"Nature"},{"issue":"36","key":"10.1016\/j.biopha.2025.118773_bib41","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2107207118","article-title":"Allosteric MEK inhibitors act on BRAF\/MEK complexes to block MEK activation","volume":"118","author":"Gonzalez-Del Pino","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2025.118773_bib42","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00109-012-0953-5","article-title":"Combination of MEK-ERK inhibitor and hyaluronic acid has a synergistic effect on anti-hypertrophic and pro-chondrogenic activities in osteoarthritis treatment","volume":"91","author":"Prasadam","year":"2013","journal-title":"J. Mol. Med (Berl. )"},{"key":"10.1016\/j.biopha.2025.118773_bib43","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.addr.2018.12.015","article-title":"Articular fibrocartilage - why does hyaline cartilage fail to repair?","volume":"146","author":"Armiento","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"6","key":"10.1016\/j.biopha.2025.118773_bib44","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1002\/art.11014","article-title":"In vivo selective inhibition of mitogen-activated protein kinase kinase 1\/2 in rabbit experimental osteoarthritis is associated with a reduction in the development of structural changes","volume":"48","author":"Pelletier","year":"2003","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.biopha.2025.118773_bib45","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2021.12469","article-title":"MAPK inhibitors protect against early\u2011stage osteoarthritis by activating autophagy","volume":"24","author":"Lan","year":"2021","journal-title":"Mol. Med Rep."},{"key":"10.1016\/j.biopha.2025.118773_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.938133","article-title":"Selumetinib - a potential small molecule inhibitor for osteoarthritis treatment","volume":"13","author":"Zheng","year":"2022","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2025.118773_bib47","unstructured":"\"Cotellic: EPAR - Product Information,\" Roche Pharma AG, 003960 - II\/0025, 2015. Accessed: 28-07-2022. [Online]. Available: \u3008https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/cotellic-epar-product-information_en.pdf\u3009."},{"issue":"9","key":"10.1016\/j.biopha.2025.118773_bib48","doi-asserted-by":"crossref","first-page":"967","DOI":"10.2217\/fon-2018-0659","article-title":"Cobimetinib in malignant melanoma: how to MEK an impact on long-term survival","volume":"15","author":"Indini","year":"2019","journal-title":"Future Oncol."}],"updated-by":[{"DOI":"10.1016\/j.biopha.2026.119004","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T00:00:00Z","timestamp":1768608000000}},{"DOI":"10.1016\/j.biopha.2026.119004","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000}}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225009679?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225009679?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T07:05:02Z","timestamp":1777014302000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225009679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":48,"alternative-id":["S0753332225009679"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118773","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A phenotype-driven data and drug repurposing strategy used to identify potential treatments targeting chondrocyte hypertrophy in osteoarthritis","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118773","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118773"}}